, Volume 27, Issue 4, pp 673–682 | Cite as

Antibacterial effect and proteomic analysis of graphene-based silver nanoparticles on a pathogenic bacterium Pseudomonas aeruginosa

  • Tingting He
  • Haitao Liu
  • Yazhou Zhou
  • Juan Yang
  • Xiaonong Cheng
  • Haifeng Shi


Graphene-based silver nanoparticles (Ag NPs–GE) material has been developed and demonstrated antibacterial effect against Escherichia coli and Pseudomonas aeruginosa. In this study, the antibacterial activity and mechanism on P. aeruginosa were investigated. The experiments results showed the minimum bactericidal concentration of Ag NPs–GE to P. aeruginosa is 20 μg/ml. When P. aeruginosa were exposed to 20 μg/ml Ag NPs–GE for 1 h, the cell wall was breakdown. In order to study the mechanism of antibacterial effect of Ag NPs–GE, two-dimensional electrophoresis was carried out to compare the protein expressional profiles of P. aeruginosa exposed to 5 μg/ml Ag NPs–GE or 5 μg/ml AgNO3 with the untreated bacteria. Identification of differentially expressed protein was performed by MALDI–TOF/TOF MS. The change of proteomic profile induced by Ag NPs–GE was distinct from that induced by AgNO3. Seven identified proteins were found induced and nine proteins were suppressed by Ag NPs–GE. Five identified proteins were found induced and twenty proteins were suppressed by AgNO3. In addition, either Ag NPs–GE or AgNO3 suppressed the expression of eight proteins, amidotransferase, 30S ribosomal protein S6, bifunctional proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase, arginyl-tRNA synthetase, nitroreductase, acetolactate synthase 3, methionyl-tRNA synthetase and periplasmic tail-specific protease. Furthermore, gene ontology analysis and KEGG pathway analysis were used to characterize the functions of those proteins.


Silver nanoparticles Proteomics 2-DE Pseudomonas aeruginosa 



This work was supported by the National Science Foundation of China (31271272, 31071030, 50902061), Jiangsu university startup fund (10JDG021).

Supplementary material

10534_2014_9756_MOESM1_ESM.doc (2.3 mb)
Supplementary material 1 (DOC 2401 kb)


  1. Benn TM, Westerhoff P (2008) Nanoparticle silver released into water from commercially available sock fabrics. Environ Sci Technol 42(11):4133–4139PubMedCrossRefGoogle Scholar
  2. Berti L et al (2005) DNA-templated photoinduced silver deposition. J Am Chem Soc 127(32):11216–11217PubMedCrossRefGoogle Scholar
  3. Bradford A et al (2009) Impact of silver nanoparticle contamination on the genetic diversity of natural bacterial assemblages in estuarine sediments. Environ Sci Technol 43(12):4530–4536PubMedCrossRefGoogle Scholar
  4. Chopra I et al (2008a) Treatment of health-care-associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect Dis 8(2):133–139PubMedCrossRefGoogle Scholar
  5. Chopra I et al (2008b) Treatment of health-care-associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect Dis 8(2):133–139PubMedCrossRefGoogle Scholar
  6. Galdiero S et al (2007) beta-Barrel membrane bacterial proteins: structure, function, assembly and interaction with lipids. Curr Protein Pept Sci 8(1):63–82PubMedCrossRefGoogle Scholar
  7. Gill SR et al (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187(7):2426–2438PubMedCentralPubMedCrossRefGoogle Scholar
  8. Giske CG et al (2008) Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52(3):813–821PubMedCentralPubMedCrossRefGoogle Scholar
  9. Handa N et al (2005) Crystal structure of a novel polyisoprenoid-binding protein from Thermus thermophilus HB8. Protein Sci 14(4):1004–1010PubMedCentralPubMedCrossRefGoogle Scholar
  10. Hayashi K et al (2006) Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2(2006):0007PubMedGoogle Scholar
  11. He t et al (2013) Characterization of antibacterial effects of novel silver nanoparticles: a case study on Pseudomonas as a model for gram-negative bacteria. Adv Mater Res 621(2013):83–86Google Scholar
  12. Hollenstein K et al (2007) Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol 17(4):412–418PubMedCrossRefGoogle Scholar
  13. Irazusta V et al (2012) Proteomic study of the yeast Rhodotorula mucilaginosa RCL-11 under copper stress. Biometals 25(3):517–527PubMedCrossRefGoogle Scholar
  14. Jain P, Pradeep T (2005) Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng 90(1):59–63PubMedCrossRefGoogle Scholar
  15. Jena P et al (2012) Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int J Nanomed 7:1805–1818Google Scholar
  16. Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26(2):131–138PubMedCrossRefGoogle Scholar
  17. Ko KM et al (2007) PYP-1, inorganic pyrophosphatase, is required for larval development and intestinal function in C. elegans. FEBS Lett 581(28):5445–5453PubMedCrossRefGoogle Scholar
  18. Kurisu G et al (2001) Structure of the electron transfer complex between ferredoxin and ferredoxin-NADP(+) reductase. Nat Struct Biol 8(2):117–121PubMedCrossRefGoogle Scholar
  19. Lee D et al (2005) Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 21(21):9651–9659PubMedCrossRefGoogle Scholar
  20. Lee S et al (2009) Eco-toxicity of commercial silver nanopowders to bacterial and yeast strains. Biotechnol Bioprocess Eng 14(4):490–495CrossRefGoogle Scholar
  21. Li P et al (2005) Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16(9):1912–1917CrossRefGoogle Scholar
  22. Li WR et al (2011) Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 24(1):135–141PubMedCrossRefGoogle Scholar
  23. Liang HW et al (2011) Highly active carbonaceous nanofibers: a versatile scaffold for constructing multifunctional free-standing membranes. ACS Nano 5(10):8148–8161PubMedCrossRefGoogle Scholar
  24. Lok CN et al (2006) Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 5(4):916–924PubMedCrossRefGoogle Scholar
  25. Lok CN et al (2007) Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 12(4):527–534PubMedCrossRefGoogle Scholar
  26. Lundqvist M et al (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38):14265–14270PubMedCentralPubMedCrossRefGoogle Scholar
  27. Morones JR et al (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16(10):2346–2353PubMedCrossRefGoogle Scholar
  28. Murphy CJ et al (2005) Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chemi B 109(29):13857–13870CrossRefGoogle Scholar
  29. Navarro E et al (2008) Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 42(23):8959–8964PubMedCrossRefGoogle Scholar
  30. Neal AL (2008) What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 17(5):362–371PubMedCrossRefGoogle Scholar
  31. Otani M et al (2001) Heat-shock-induced proteins from Myxococcus xanthus. J Bacteriol 183(21):6282–6287PubMedCentralPubMedCrossRefGoogle Scholar
  32. Page MGP, Heim J (2009) Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol 9(5):558–565PubMedCrossRefGoogle Scholar
  33. Percival SL et al (2005) Bacterial resistance to silver in wound care. J Hosp Infect 60(1):1–7PubMedCrossRefGoogle Scholar
  34. Rai M et al (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76–83PubMedCrossRefGoogle Scholar
  35. Schulz GE (2000) beta-Barrel membrane proteins. Curr Opin Struct Biol 10(4):443–447PubMedCrossRefGoogle Scholar
  36. Shrivastava S et al (2007) Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18(22):225103.
  37. Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27(2–3):341–353PubMedCrossRefGoogle Scholar
  38. Smith A et al (2012) Exposure of Staphylococcus aureus to silver(I) induces a short term protective response. Biometals 25(3):611–616PubMedCrossRefGoogle Scholar
  39. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 275(1):177–182PubMedCrossRefGoogle Scholar
  40. Stancik LM et al (2002) pH-dependent expression of periplasmic proteins and amino acid catabolism in Escherichia coli. J Bacteriol 184(15):4246–4258PubMedCentralPubMedCrossRefGoogle Scholar
  41. Zhou Y et al (2013) Highly stable and dispersive silver nanoparticle–graphene composites by a simple and low-energy-consuming approach and their antimicrobial activity. Small 9(20):3445–3454PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Tingting He
    • 1
  • Haitao Liu
    • 1
  • Yazhou Zhou
    • 2
  • Juan Yang
    • 2
  • Xiaonong Cheng
    • 2
  • Haifeng Shi
    • 1
  1. 1.Institute of Life SciencesJiangsu UniversityZhenjiangPeople’s Republic of China
  2. 2.School of Material Science and EngineeringJiangsu UniversityZhenjiangPeople’s Republic of China

Personalised recommendations